GI DisordersNCT07069816
Esophageal Motility and Gastric Emptying Disorders Among Different Thyroid Dysfunction
An observational study of GI Disorders, run by Assiut University at 1 site in Egypt.
Trial summary
Detect prevalence of different gastroparesis symptoms among different thyroid disorders Effect of thyroid disorders either hypothyroidism, hyperthyroidism and subclinical disorders in upper gastro motility Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- GI Disorders
- What is being tested?
- Scintigraphy
- Type of treatment
- Surgery or procedure
- How many people
- 100 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Aug 2025to 1 Sep 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Study population: All patient diagnosed as hypothyroidism, hyperthyroidism and subclinical thyroid disorders, age above 18 years
Who may be able to join
- all patient diagnosed as hypothyroidism, hyperthyroidism and subclinical thyroid disorders in diabetic and endocrinological centre in Assiut university hospitals, age above 18 years
Who cannot join
- patients take any drugs affect GIT motility Patients with acute infection Patients with major surgeries or recent trauma less than 6 months Patients known to have malignancy Patients with previous history of bariatric surgery Patients with history of liver cirrhosis or inflammatory bowel diseases
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site
Esraa
Asyut
Esraa Mohamed Galal, 010 23383033, Esraa.16266335@med.aun.edu.eg
About this study
Detect prevalence of different gastroparesis symptoms among different thyroid disorders Effect of thyroid disorders either hypothyroidism, hyperthyroidism and subclinical disorders in upper gastro motility
- Conditions
- GI Disorders
- Being tested
- Scintigraphy
- Medical subject headings
- Digestive System Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ScintigraphyRadiation
non invasive method in which the test meals and acquisition procedures have been standardized and the results are largely operator independent
ScintigraphyRadiation
Non invasive method in which the test meals and acquisition procedures have been standardized
What is being measured
The primary outcome is the main question the study is designed to answer.
Detect prevalence of different gastroparesis symptoms among different thyroid disorders
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jul 2025
- Study start1 Aug 2025 (estimated)
- Primary completion1 Jul 2026 (estimated)
- Study completion1 Sep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for GI DisordersStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Esraa mohamed galal ahmed, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07069816
- Sponsor's protocol ID
- GIT and thyroid dysfunction
- Status last verified
- Jul 2025
- First submitted
- 8 Jul 2025
- Last updated
- 17 Jul 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Esophageal Motility and Gastric Emptying Disorders Among Different Thyroid Dysfunction
- ClinicalTrials.gov ID
- NCT07069816
- Acronym / sponsor ID
- GIT and thyroid dysfunction
- Conditions
- GI Disorders
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 1 Aug 2025 (estimated)
- Primary completion
- 1 Jul 2026 (estimated)
- Study completion
- 1 Sep 2026 (estimated)
- First posted
- 17 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Detect prevalence of different gastroparesis symptoms among different thyroid disorders Effect of thyroid disorders either hypothyroidism, hyperthyroidism and subclinical disorders in upper gastro motility
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- All patient diagnosed as hypothyroidism, hyperthyroidism and subclinical thyroid disorders, age above 18 years
Key inclusion criteria (1 listed)
- all patient diagnosed as hypothyroidism, hyperthyroidism and subclinical thyroid disorders in diabetic and endocrinological centre in Assiut university hospitals, age above 18 years
Key exclusion criteria (1 listed)
- patients take any drugs affect GIT motility Patients with acute infection Patients with major surgeries or recent trauma less than 6 months Patients known to have malignancy Patients with previous history of bariatric surgery Patients with history of liver cirrhosis or inflammatory bowel diseases
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Scintigraphynon invasive method in which the test meals and acquisition procedures have been standardized and the results are largely operator independent | Radiation | – |
| ScintigraphyNon invasive method in which the test meals and acquisition procedures have been standardized | Radiation | – |
Primary outcome
Detect prevalence of different gastroparesis symptoms among different thyroid disorders
Time frame: Baseline
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jul 2025.
Related trials for GI Disorders
Active, not recruitingObservational study
A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
Colitis, Ulcerative
Active, not recruitingPhase 1/2
A Beta-only IL-2 ImmunoTherapY Study
Advanced Solid Tumor, Unresectable Solid Tumor
RecruitingPhase 1
A Study of MGC030 in Participants With Advanced Solid Tumors
Urothelial Cancer, GastroEsophageal Cancer
Active, not recruitingPhase 3
Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
Eosinophilic Esophagitis
Recruiting
Implementation of a Pain Management Plan in Major Open Abdominal Surgeries.
Abdomen Cancer, Pancreas Adenocarcinoma (MSI-H)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of GI Disorders, run by Assiut University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 17 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Esraa Mohamed Galal (010 23383033, Esraa.16266335@med.aun.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Detect prevalence of different gastroparesis symptoms among different thyroid disorders (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2025.